Talented People

PCC is training and helping to retain the best prostate cancer research leaders – current and next generation. How do we do this? Through the following:

Rising Star

This program provides salary and research support for outstanding research scientists initiating careers as independent investigators in prostate cancer research – an important time during which we need to support the next generation or risk losing them to other fields or countries. The awards provide the opportunity for research scientists within 5 years of their first academic or research appointment to develop and demonstrate independence in initiating and conducting prostate cancer research.

For a list of current recipients, click here.

Clinician Scientist

This program provides salary and research support for outstanding clinician scientists initiating careers as independent investigators/junior faculty in prostate cancer research. The award is regarded as invaluable support that allows researchers to focus on making advances in their research. For a list of current award recipients, please click here. This program has now evolved into the Rising Star program.

 




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Study to tackle unresolved link between prostate cancer treatment and cardiovascular disease

Movember Foundation and Prostate Cancer Canada team up to award $3+ million grant TORONTO, ON (April 15, 2015) - Funded by the Movember Foundation and selected by Prostate Cancer Canada (PCC), Dr. More

$180,000 commitment to Prostate Cancer Canada by the Building Trades of Alberta

Red Deer – March 19th, 2015 - Prostate Cancer Canada and the Building Trades of Alberta today announced new funding that will support groundbreaking research into the prognosis and treatment of prostate cancer. More

Prostate Cancer Canada’s Step Up Challenge in Calgary raises $170,000

Corporate Calgary raised funds for prostate cancer research by racing up 5 skyscrapers. More


Click here for news archive